Role of selective serotonin reuptake inhibitors in psychiatric disorders: a comprehensive review
Top Cited Papers
- 1 February 2003
- journal article
- review article
- Published by Elsevier in Progress in Neuro-Psychopharmacology and Biological Psychiatry
- Vol. 27 (1), 85-102
- https://doi.org/10.1016/s0278-5846(02)00338-x
Abstract
No abstract availableKeywords
This publication has 148 references indexed in Scilit:
- Clinical and Physiological Consequences of Rapid Tryptophan DepletionNeuropsychopharmacology, 2000
- Inhibition of CYP2C9 by selective serotonin reuptake inhibitors in vitro: studies of phenytoin p‐hydroxylationBritish Journal of Clinical Pharmacology, 1997
- A comparison of the post‐marketing safety of four selective serotonin re‐uptake inhibitors including the investigation of symptoms occurring on withdrawalBritish Journal of Clinical Pharmacology, 1996
- The effects of selective serotonin reuptake inhibitors and their metabolites on S‐mephenytoin 4'‐hydroxylase activity in human liver microsomes.British Journal of Clinical Pharmacology, 1995
- Prozac (fluoxetine, lilly 110140), the first selective serotonin uptake inhibitor and an antidepressant drug: Twenty years since its first publicationLife Sciences, 1995
- Serotonin uptake inhibitors are superior to imipramine and alprazolam in alleviating panic attacksInternational Clinical Psychopharmacology, 1995
- Pharmacology of Antidepressants—Characteristics of the Ideal DrugMayo Clinic Proceedings, 1994
- A double-blind comparison of moclobemide and fluoxetine in the treatment of depressive disordersInternational Clinical Psychopharmacology, 1993
- Fluoxetine, a selective inhibitor of serotonin uptakeMedicinal Research Reviews, 1991
- Neuroendocrine and behavioral effects of dietary tryptophan restriction in healthy subjectsLife Sciences, 1988